Europe Market Split by Country The GLP-1 diabetes treatment drugs market in Europe is projected to grow from USD 1,708.0 million in 2025 to USD 14,836.7 million by 2035, registering a CAGR of 23.3% over the forecast period
Since peptide based medications require cold chain handling, reputable pharmacies ship the vials in temperature controlled packaging with ice packs
A larger model (enabled by 3,500 GPUs) can be fine-tuned faster and generate more candidate compounds in parallel
Smits P, Saada A, Wortmann SB, Heister AJ, Brink M, Pfundt R, et al
We considered the use of other objective end points, including QST and IENFD, but many of our study centers did not have the necessary equipment for QST and/or lacked laboratory staff trained in IENFD biopsy evaluation
Some patients are circumventing doctors offices to get access buying the drugs online, from other countries, or through compounding pharmacies, often without medical supervision